• Nektar Therapeutics (NASDAQ:NKTR) Given "Buy" Rating at HC Wainwright

    Source: Buzz FX / 25 Feb 2025 07:11:19   America/Chicago


    Nektar Therapeutics (NASDAQ:NKTR) Given "Buy" Rating at HC Wainwright Written by MarketBeat February 25, 2025 Share Link copied to clipboard. Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) 's stock had its "buy" rating reaffirmed by
    Read more...
Share on,